Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis
Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis
About this item
Full title
Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
The New England journal of medicine, 2019-03, Vol.380 (10), p.981-983
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Seven patients with pustular psoriasis, three with mutations in
IL36RN
, were treated with a monoclonal antibody against interleukin-36 receptor and had amelioration of their skin disease.
Alternative Titles
Full title
Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2188641788
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2188641788
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMc1811317
